Past Seminars/ Symposiums

June 7, 2019
"Development of a Precision Medicine Program in Ovarian Cancer and Beyond"
Boris J. Winterhoff, MD, MS---Assistant Professor, Department of Obstetrics, Gynecology and Women’s Health, University of Minnesota

May 31, 2019
"Using Genetic Testing to Improve Drug Efficacy, Save Lives, and Cut Costs"
UnitedHealth Group Research & Development

May 3, 2019
"A Functional Genomic Platform for Discovery of Novel Targeting Strategies in Acute Myeloid Leukemia"
Jeffrey Tyner, PhD---Associate Professor of Cell, Developmental and Cancer Biology; Co-Director, Translational Oncology Program, Knight Cancer Institute, Oregon Health and Sciences University

February 1, 2019
"Pharmacogenomics at Mayo Clinic: The Intersection of Patient Care and Research"
Suzette J. Bielinski, MEd, PhD---Professor of Epidemiology, Mayo Clinic College of Medicine and Science; Consultant, Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic

September 7, 2018
"International Efforts in Transplantation Genomics: Large Research Cohorts"
Brendan James Keating, D.Phil
Research Assistant Professor of Surgery
Perelman School of Medicine, University of Pennsylvania

March 3, 2018
"The Alcohol Flushing Response: Implications for Human Health and Anesthetic Management"
Dr. Eric Gross
Dept. of Anesthesiology, Perioperative and Pain Medicine at Stanford University

October 6, 2017
"Health Informatics to Facilitate Precision Medicine"
Rui Zhang, PhD—Assistant Professor, Department of Pharmaceutical Care & Health Systems and Institute for Health Informatics, University of Minnesota

November 3, 2017
"Making Complex Cancer Genomics Data Accessible and Interpretable"
Nikolaus Schultz, PhD—Head of Knowledge Systems, Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center

September 1, 2017
"Pharmacogenomics-Guided Antidepressant Treatment for Major Depressive Disorder -- A Systematic Review"
Eric W. Dieperink, MD, Minneapolis Veterans Affairs Medical Center

April 12, 2017
PMHC Seminar: Working Together on Pharmacogenetics: Report on a Tribal-University Partnership
Wylie Burke, M.D., Ph.D.

March 27, 2017
Precision Medicine and Health Disparities Summit: Transforming health and advancing equity

A workshop to consider precision medicine in the context of health disparities, to introduce the intent and initiatives of the new Minnesota Precision Medicine Collaborative (MPMC), and to broadly discuss the potential for new research collaborations among University of Minnesota faculty, community partners, and healthcare systems within the state.

March 10, 2017
PMHC Seminar: "Creation of a National Biobank for the Precision Medicine Initiative"
Stephen N. Thibodeau, PhD
Professor, Mayo Clinic College of Medicine
Co-director of the Molecular Genetics Laboratory, a clinical laboratory in the Department of Laboratory Medicine and Pathology

February 10, 2017
PMHC Seminar"PDF icon Developing Pharacogenomic Services from an Academic Lab - the OneOme Experience"
Josiah Allen, Director of Medical Affairs, OneOme, LLC
Paul Owen, CEO, OneOme, LLC

January 27, 2017
PMHC Seminar: PDF icon "Human Genomic Control of the Microbiome"
Ran Blekhman, PhD
Assistant Professor
Department of Genetics, Cell Biology, and Development
Department of Ecology, Evolution, and Behavior

December 9, 2016
University Grand Challenges Presentations 

U of M Precision Medicine Grand Challenge in Health Disparities.  Minnesota Precision Medicine Collaborative: Transforming health and advancing equity.  Pamala Jacobson, College of Pharmacy

Exploratory Grand Challenge.  Development of a clinical precision medicine program in ovarian cancer as a paradigm for 21st century tailored health care solutions.  Boris Winterhoff, Obstetrics, Gynecology & Women’s Health

Exploratory Grand Challenge.  A community-based approach toward advancing personalized medicine in under-served population.  Robert Straka, Experimental and Clinical Pharmacology

December 6, 2016
"How Patients Are Creating Medicine’s Future: From Citizen Science to Precision Medicine"

Jason Bobe (Mount Sinai), Ernesto Ramirez (formerly Quantified Self and now Fitabase), legal thinker Barbara Evans (who has written cutting-edge work on building data commons), and our very own KK Sinha.

November 16, 2016
"Pharmacogenetics in Children with ADHD"
Jacob Brown, PharmD, MSc, Assistant Professor, Department of Pharmacy Practice and Pharmaceutical Sciences, University of MN-Duluth

November 16, 2016
"The Electronic Medical Record as a Tool for Precision Medicine Research and Implementation"
Sara Van Driest, MD, PhD, Pediatrician, Vanderbilt University

October 7, 2016
University of Minnesota Genomics Center (UMGC) GenoFest: Annual Open House and Festival of Genomics

Highlighting the arrival of three new technologies: Pacific Biosciences Sequel, 10X Genomics Chromium System, and Illumina HiSeq 4000

October 5-7, 2016
Moving Toward Precision Healthcare in Children’s Mental Health: New Perspectives, Methodologies, and Technologies in Therapeutics and Prevention

October 5, 2016
"Systems Medicine, Precision Medicine and Proactive P4 Medicine: Transforming Healthcare with Scientific Wellness"

Leroy Hood, Ph.D, President & Co-founder, Institute for Systems Biology, SVP & CSO,Providence Health and Services

Dr. Hood is very well-known for his pioneering work in the fields of systems biology and systems medicine. His ground breaking work led to much of the genomic and proteomic instrumentation that we have today.

April 15, 2016
"Experiences in Genomic Medicine at Marshfield Clinic and Essentia Health"

Cathy McCarty, MPH, PhD
Principal Research Scientist and Director of Research Division, Essentia Institute of Rural Health, Duluth, MN and Adjunct Professor in School of Public Health, University of MN

Her research interests include population genetics, rural health, pharmacoepidemiology and pharmacogenomics in breast cancer, endometriosis, diabetes, cardiovascular disease, smoking, obesity and trauma.

March 17, 2016
Liewei Wang, MD, PhD
Associate Director of the Pharmacogenomics Program
Dept of Molecular Pharmacology and Experimental Therapeutics
Mayo Clinic Rochester

Pharmacogenomics: Discovery and Implementation

Built on the infrastructure created by the Mayo-NIH PGRN and Mayo-NIH Breast SPORE, within the Mayo Center for Individualized Medicine (CIM), we are working on projects related to PGx implementation as well as PGx discovery and translational studies in breast cancer, prostate cancer and cardiovascular disease. We plan to sequence 10K Mayo Rochester biobank DNA samples using captured NextGen Sequencing of 76 PGx genes. These information would be linked to our EMR for retrospective and prospective analysis. In addition, with the Pharmacogenomics Program of CIM, we have performed breast cancer and prostate cancer genome guided treatment trial to identify and understand resistance mechanisms of standard therapies. 

November 6, 2015
Health Informatics and Personalized Medicine
Dr. Constantin Aliferis, MD, PhD, Professor and Director of the Institute for Health Informatics and UMN Chief Research Informatics Officer is speaking on big data analytics at the UMN and his plans and vision as our new Director of Health Informatics.

August 13, 2015
Bithia Fikru, PharmD, PhD canidate, College of Pharmacy
MN Health Care Insurance Providers and Their Coverage for Pharmacogenomic Testing

Brian Van Ness, PhD, Medical School
Predicting Response and Resistance to Proteosome Inhibitors in Multiple Myeloma.  

June 9, 2015
Tim Schacker, MD, Medical School
Biospecimen Repository

June 8, 2015
Precision Medicine Symposium

March 27, 2015
Joshua Baller, PhD, Minnesota Supercomputing Institute

January 30, 2015
Boris Winterhoff, MD, Medical School
Bio Portal as an Example of Individualized Medicine in Cancer

November 21, 2014
Pamala Jacobson, PharmD, College of Pharmacy
Personalized Medicine

Pharmacogenomics Conference

Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Confernece on June 22 was at capacity with over 310 registrants in attendance.  Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas such as analgesics and how to apply PGx in minority populations, clinical PGx guidelines, use of PGx in children, implementation of PGx in practice settings, insurance reimbursement, and evidence for cost effectiveness and improved quality of care.  Participants were given the opportunity to have personal PGx testing done by OneOme and received their results at check-in.  See speaker information, pictures and videos here

Stay tuned for information on our next PGx Conference - date TBD.

2016 Precision Medicine Conference Completed

precision med 2016

The 2016 Precision Medicine Conference had 300 attendees and the first 150 registrants were genotyped.